GANX·36269B105·US·equity·Healthcare - Biotechnology
GANX (GAIN THERAPEUTICS INC) is held by 25 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), JONES FINANCIAL COMPANIES LLLP ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($868,527). Net institutional sentiment: Mixed.
See how GANX's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Showing 1-20 of 36
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer